These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 3145794

  • 1. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.
    Gunness-Hey M, Gera I, Fonseca J, Raisz LG, Hock JM.
    Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794
    [Abstract] [Full Text] [Related]

  • 2. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M, Hock JM, Gera I, Fonseca J, Poser J, Bevan J, Raisz LG.
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [Abstract] [Full Text] [Related]

  • 3. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]

  • 4. Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats.
    Gunness-Hey M, Hock JM.
    Bone; 1989 Feb; 10(6):447-52. PubMed ID: 2624826
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats.
    Hock JM, Gunness-Hey M, Poser J, Olson H, Bell NH, Raisz LG.
    Calcif Tissue Int; 1986 Feb; 38(2):79-86. PubMed ID: 3082498
    [Abstract] [Full Text] [Related]

  • 6. Indomethacin does not inhibit the anabolic effect of parathyroid hormone on the long bones of rats.
    Gera I, Hock JM, Gunness-Hey M, Fonseca J, Raisz LG.
    Calcif Tissue Int; 1987 Apr; 40(4):206-11. PubMed ID: 3107773
    [Abstract] [Full Text] [Related]

  • 7. 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.
    Burnatowska-Hledin MA, Doyle TM, Eadie MJ, Mayor GH.
    J Lab Clin Med; 1986 Aug; 108(2):96-102. PubMed ID: 3755457
    [Abstract] [Full Text] [Related]

  • 8. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo.
    Hock JM, Hummert JR, Boyce R, Fonseca J, Raisz LG.
    J Bone Miner Res; 1989 Jun; 4(3):449-58. PubMed ID: 2527459
    [Abstract] [Full Text] [Related]

  • 9. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone.
    Gunness-Hey M, Hock JM.
    Metab Bone Dis Relat Res; 1984 Jun; 5(4):177-81. PubMed ID: 6738355
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats.
    Hock JM, Fonseca J, Gunness-Hey M, Kemp BE, Martin TJ.
    Endocrinology; 1989 Oct; 125(4):2022-7. PubMed ID: 2791976
    [Abstract] [Full Text] [Related]

  • 11. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
    Finch JL, Brown AJ, Mori T, Nishii Y, Slatopolsky E.
    J Bone Miner Res; 1992 Jul; 7(7):835-9. PubMed ID: 1642151
    [Abstract] [Full Text] [Related]

  • 12. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells.
    Klaus G, von Eichel B, May T, Hügel U, Mayer H, Ritz E, Mehls O.
    Endocrinology; 1994 Oct; 135(4):1307-15. PubMed ID: 7523093
    [Abstract] [Full Text] [Related]

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 14. The effect of vitamin D on bone in vivo.
    Tam CS, Heersche JN, Jones G, Murray TM, Rasmussen H.
    Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
    [Abstract] [Full Text] [Related]

  • 15. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A, Geertsma-Kleinekoort WM, Van Den Bemd GJ, Buurman CJ, Birkenhäger JC, Pols HA, Van Leeuwen JP.
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone does not enhance the anabolic effect of human parathyroid hormone (1-34) on bone in aging multiparous and virgin rats.
    Hock JM, Wood RJ.
    Mech Ageing Dev; 1995 Nov 24; 85(2-3):183-97. PubMed ID: 8786664
    [Abstract] [Full Text] [Related]

  • 17. Effects of clomiphene and tamoxifen in vivo on the bone-resorbing effects of parathyroid hormone and of high oral doses of calcitriol (1,25(OH)2D3) in rats with intact ovarian function consuming low calcium diet.
    Goulding A, Gold E, Fisher L.
    Bone Miner; 1990 Mar 24; 8(3):185-93. PubMed ID: 2322693
    [Abstract] [Full Text] [Related]

  • 18. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Mar 24; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 19. Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone.
    Hock JM, Fonseca J.
    Endocrinology; 1990 Oct 24; 127(4):1804-10. PubMed ID: 2401235
    [Abstract] [Full Text] [Related]

  • 20. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
    Marcus R, Orner FB, Brickman AS.
    Endocrinology; 1980 Nov 24; 107(5):1593-9. PubMed ID: 6253269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.